<p>NEW YORK, Aug. 02, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Inozyme Pharma, Inc. (“Inozyme” or the “Company”) (NASDAQ: INZY). Such investo
NZD/USD may struggle to hold its ground ahead of the RBNZ meeting on June 24 as the RSI appears to be on track to threaten the bullish formation from March.
Leave a Comment